UA129409C2 - Лікування та профілактика хвороби денге - Google Patents

Лікування та профілактика хвороби денге Download PDF

Info

Publication number
UA129409C2
UA129409C2 UAA202202003A UAA202202003A UA129409C2 UA 129409 C2 UA129409 C2 UA 129409C2 UA A202202003 A UAA202202003 A UA A202202003A UA A202202003 A UAA202202003 A UA A202202003A UA 129409 C2 UA129409 C2 UA 129409C2
Authority
UA
Ukraine
Prior art keywords
compound
denotes
copies
day
dengue
Prior art date
Application number
UAA202202003A
Other languages
English (en)
Ukrainian (uk)
Inventor
Олівія Габріела М. Геталс
Оливия Габриэла М Геталс
Барт Рудольф Романі Кестелеїн
Барт Рудольф Романи Кестелеин
Барт Анрі Терезія Ступс
Барт Анри Терезия Ступс
Жан-Франсуа Бонфанті
Жан-Франсуа Бонфанти
Тім Х'юго Марі Джонкерс
Тим Хьюго Мари Джонкерс
Лок Марнікс Ван
Лок Марникс Ван
Сюзанне Каптайн
Йохан Нейц
Original Assignee
Янссен Фармасьютікалз, Інк.
Янссен Фармасьютикалз, Инк.
Католіке Універсітейт Левен
Католике Университейт Левен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармасьютікалз, Інк., Янссен Фармасьютикалз, Инк., Католіке Універсітейт Левен, Католике Университейт Левен filed Critical Янссен Фармасьютікалз, Інк.
Publication of UA129409C2 publication Critical patent/UA129409C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
UAA202202003A 2019-11-15 2020-11-13 Лікування та профілактика хвороби денге UA129409C2 (uk)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP19209593 2019-11-15
EP19213851 2019-12-05
EP20171172 2020-04-23
PCT/EP2020/082102 WO2021094563A1 (en) 2019-11-15 2020-11-13 Treatment and prevention of dengue disease

Publications (1)

Publication Number Publication Date
UA129409C2 true UA129409C2 (uk) 2025-04-16

Family

ID=73288639

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA202202003A UA129409C2 (uk) 2019-11-15 2020-11-13 Лікування та профілактика хвороби денге

Country Status (14)

Country Link
US (1) US20220409583A1 (https=)
EP (1) EP4058019A1 (https=)
JP (1) JP2023502053A (https=)
KR (1) KR20220101679A (https=)
CN (1) CN114980884A (https=)
AU (1) AU2020382911A1 (https=)
BR (1) BR112022009199A2 (https=)
CA (1) CA3161338A1 (https=)
IL (1) IL292970A (https=)
MX (1) MX2022005879A (https=)
PH (1) PH12022551160A1 (https=)
TW (1) TW202132269A (https=)
UA (1) UA129409C2 (https=)
WO (1) WO2021094563A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023218285A1 (en) * 2022-05-12 2023-11-16 Janssen Pharmaceuticals, Inc. Treatment or prevention of dengue viral infection
WO2025248536A1 (en) * 2024-05-29 2025-12-04 Zydus Lifesciences Limited Novel oxime derivatives to treat viral infections
WO2025253267A1 (en) 2024-06-06 2025-12-11 Janssen Pharmaceuticals, Inc. Combination of mosnodenvir and close analogs with nitd-688 for use in the treatment and prevention of dengue disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20160086B1 (ar) 2015-05-08 2021-08-17 2 Katholieke Univ Leuven Ku Leuven Research And Development مشتقات اندول مستبدلة احاديا او ثنائيا بصفتها مانعات للتكاثر الفيروسي لحمى الفنك
JOP20170069B1 (ar) 2016-04-01 2021-08-17 1 Janssen Pharmaceuticals Inc مشتقات اندولين مستبدلة بصفتها مانعات للتكاثر الفيروسي لحمى الفنك

Also Published As

Publication number Publication date
KR20220101679A (ko) 2022-07-19
CA3161338A1 (en) 2021-05-20
EP4058019A1 (en) 2022-09-21
JP2023502053A (ja) 2023-01-20
TW202132269A (zh) 2021-09-01
US20220409583A1 (en) 2022-12-29
CN114980884A (zh) 2022-08-30
PH12022551160A1 (en) 2023-09-25
WO2021094563A1 (en) 2021-05-20
MX2022005879A (es) 2022-06-14
AU2020382911A1 (en) 2022-06-30
IL292970A (en) 2022-07-01
BR112022009199A2 (pt) 2022-07-26

Similar Documents

Publication Publication Date Title
UA129409C2 (uk) Лікування та профілактика хвороби денге
Wu et al. An update on current therapeutic drugs treating COVID-19
EP4065116B1 (en) Capsid inhibitors for the prevention of hiv
EP2142192B1 (en) Compositions and kits for treating influenza
JP6810972B2 (ja) Ｈｉｖおよびエイズの治療および予防方法
EA020283B1 (ru) Средство для профилактики и лечения высокопатогенных инфекционных заболеваний
EP3955908B1 (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
KR20220151643A (ko) 바이러스 감염에 사용하기 위한 화합물
AU2014228035B2 (en) Novel dosing regimens of celgosivir for the treatment of dengue
KR102879944B1 (ko) Hiv 예방용 인테그라제 억제제
KR20220150348A (ko) 코로나바이러스의 치료에 조합하여 사용하기 위한 pld
Snell Examining unmet needs in infectious disease
WO2017201030A1 (en) Methods of treating viral infection
KR102824220B1 (ko) 병원체 활성 조절을 위한 제제 및 방법
EA049504B1 (ru) Лечение и профилактика лихорадки денге
US20080045482A1 (en) Compositions and methods for the treatment of viral infections
CA3169791A1 (en) Compounds for use in the treatment of coronavirus infection
WO2021249996A1 (en) Compositions comprising 2x-121 and methods for treating coronavirus infection
HK40074715A (en) Treatment and prevention of dengue disease
Islam et al. A Generalized Overview of the Possible Pharmacotherapy and Treatments against SARS-CoV-2
CA2374198A1 (en) Combination therapy for treatment of fiv infection
HK40029715B (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
HK40048893A (en) Integrase inhibitors for the prevention of hiv